Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
11.09
+0.29 (2.69%)
Jun 11, 2026, 2:34 PM EDT - Market open
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $529.75 million as of June 11, 2026. Its market cap has increased by 570.03% in one year.
Market Cap
529.75M
Enterprise Value
373.18M
1-Year Change
570.03%
Ranking
Category
Stock Price
$11.09
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has increased from $403.20M to $529.75M, an increase of 31.39%. That is a compound annual growth rate of 5.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 515.90M | 170.14% |
| Dec 31, 2025 | 190.98M | 57.83% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
| Aug 10, 2021 | 403.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gyre Therapeutics | 562.85M |
| Tectonic Therapeutic | 555.41M |
| MiMedx Group | 537.69M |
| XOMA Royalty | 524.90M |
| Altimmune | 507.58M |
| Ginkgo Bioworks Holdings | 504.96M |
| ProKidney | 501.42M |
| Prime Medicine | 501.21M |